Evocalcet is a calcimimetic agent of the phenylpyrrolidine class, primarily utilized for the treatment of secondary hyperparathyroidism in patients undergoing dialysis. By acting as an allosteric activator… Read more







Evocalcet is a calcimimetic agent of the phenylpyrrolidine class, primarily utilized for the treatment of secondary hyperparathyroidism in patients undergoing dialysis. By acting as an allosteric activator of the calcium-sensing receptor (CaSR) on the parathyroid gland, it enhances the sensitivity of these receptors to extracellular calcium, thereby suppressing the secretion of parathyroid hormone. This category includes high-quality reference standards for Evocalcet and a comprehensive range of related compounds, such as identified and non-pharmacopoeial impurities, metabolites, and stable isotope labelled versions. These materials are essential for pharmaceutical laboratories conducting rigorous analytical testing, impurity profiling, and method validation. Using these precise reference standards and stable isotope labelled internal standards ensures accurate quantification and reliable quality control during the development and routine analysis of drug products.